These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 34630403)

  • 21. Editorial: Understanding Gamma Delta T Cell Multifunctionality - Towards Immunotherapeutic Applications.
    Gustafsson K; Herrmann T; Dieli F
    Front Immunol; 2020; 11():921. PubMed ID: 32477369
    [No Abstract]   [Full Text] [Related]  

  • 22. Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias.
    Pistoia V; Tumino N; Vacca P; Veneziani I; Moretta A; Locatelli F; Moretta L
    Front Immunol; 2018; 9():984. PubMed ID: 29867961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy.
    Chen S; Lai SWT; Brown CE; Feng M
    Front Immunol; 2021; 12():635173. PubMed ID: 33790906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving Immunotherapy Against B-Cell Malignancies Using γδ T-Cell-specific Stimulation and Therapeutic Monoclonal Antibodies.
    Hoeres T; Pretscher D; Holzmann E; Smetak M; Birkmann J; Triebel J; Bertsch T; Wilhelm M
    J Immunother; 2019; 42(9):331-344. PubMed ID: 31318724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes.
    Serrano R; Wesch D; Kabelitz D
    Cells; 2020 Mar; 9(3):. PubMed ID: 32183240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells.
    Polito VA; Cristantielli R; Weber G; Del Bufalo F; Belardinilli T; Arnone CM; Petretto A; Antonucci L; Giorda E; Tumino N; Pitisci A; De Angelis B; Quintarelli C; Locatelli F; Caruana I
    Front Immunol; 2019; 10():2717. PubMed ID: 31824502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the tumor microenvironment and T cell metabolism for effective cancer immunotherapy.
    Hope HC; Salmond RJ
    Eur J Immunol; 2019 Aug; 49(8):1147-1152. PubMed ID: 31270810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-cell RNA sequencing of human breast tumour-infiltrating immune cells reveals a γδ T-cell subtype associated with good clinical outcome.
    Boufea K; González-Huici V; Lindberg M; Symeonides S; Oikonomidou O; Batada NN
    Life Sci Alliance; 2021 Jan; 4(1):. PubMed ID: 33268347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma.
    Makkouk A; Yang XC; Barca T; Lucas A; Turkoz M; Wong JTS; Nishimoto KP; Brodey MM; Tabrizizad M; Gundurao SRY; Bai L; Bhat A; An Z; Abbot S; Satpayev D; Aftab BT; Herrman M
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34916256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer.
    Mikulak J; Oriolo F; Bruni E; Roberto A; Colombo FS; Villa A; Bosticardo M; Bortolomai I; Lo Presti E; Meraviglia S; Dieli F; Vetrano S; Danese S; Della Bella S; Carvello MM; Sacchi M; Cugini G; Colombo G; Klinger M; Spaggiari P; Roncalli M; Prinz I; Ravens S; di Lorenzo B; Marcenaro E; Silva-Santos B; Spinelli A; Mavilio D
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31689241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial: CD4
    González-Navajas JM; Elkord E; Lee J
    Front Immunol; 2021; 12():737615. PubMed ID: 34552596
    [No Abstract]   [Full Text] [Related]  

  • 32. γδ T cells bring unconventional cancer-targeting to the clinic - again.
    Garber K
    Nat Biotechnol; 2020 Apr; 38(4):389-391. PubMed ID: 32265560
    [No Abstract]   [Full Text] [Related]  

  • 33. γδ T cell exhaustion: Opportunities for intervention.
    Chen D; Guo Y; Jiang J; Wu P; Zhang T; Wei Q; Huang J; Wu D
    J Leukoc Biol; 2022 Dec; 112(6):1669-1676. PubMed ID: 36000310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity.
    Lopes N; Silva-Santos B
    Eur J Immunol; 2021 Jan; 51(1):17-26. PubMed ID: 33188652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
    Yang P; Meng M; Zhou Q
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dichotomous and stable gamma delta T-cell number and function in healthy individuals.
    Ou L; Wang H; Liu Q; Zhang J; Lu H; Luo L; Shi C; Lin S; Dong L; Guo Y; Huang L; Zhu J; Yin X; Huang AC; Karakousis G; Schuchter L; Amaravadi R; Zheng C; Fan Y; Guo W; Xu X
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localized ablative immunotherapy enhances antitumor immunity by modulating the transcriptome of tumor-infiltrating Gamma delta T cells.
    Liu K; Hoover AR; Wang L; Sun Y; Valerio TI; Furrer C; Adams J; Yang J; Li M; Chen WR
    Cancer Lett; 2024 Nov; 604():217267. PubMed ID: 39307410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer.
    Li J; Cao Y; Liu Y; Yu L; Zhang Z; Wang X; Bai H; Zhang Y; Liu S; Gao M; Lu C; Li C; Guan Y; Tao Z; Wu Z; Chen J; Yuan Z
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape.
    Caforio M; Sorino C; Caruana I; Weber G; Camera A; Cifaldi L; De Angelis B; Del Bufalo F; Vitale A; Goffredo BM; De Vito R; Fruci D; Quintarelli C; Fanciulli M; Locatelli F; Folgiero V
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.